Annual SG&A
$170.53 M
+$3.03 M+1.81%
30 June 2022
Summary:
Cardiovascular Systems annual selling, general & administrative expenses is currently $170.53 million, with the most recent change of +$3.03 million (+1.81%) on 30 June 2022. During the last 3 years, it has risen by +$3.03 million (+1.81%).CSII Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$41.64 M
-$2.83 M-6.37%
31 December 2022
Summary:
Cardiovascular Systems quarterly selling, general & administrative expenses is currently $41.64 million, with the most recent change of -$2.83 million (-6.37%) on 31 December 2022.CSII Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.72 B
-$39.30 M-2.34%
31 December 2022
Summary:
Cardiovascular Systems TTM selling, general & administrative expenses is currently -$1.72 billion, with the most recent change of -$39.30 million (-2.34%) on 31 December 2022.CSII TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSII Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | +1.8% | +3.1% | -1113.2% |
5 y5 years | +1.7% | -11.2% | -1059.1% |
CSII Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time | at high | -11.1% | -1058.9% |
Cardiovascular Systems Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | - | $41.64 M(-6.4%) | $174.39 M(+0.7%) |
Sept 2022 | - | $44.48 M(-4.5%) | $173.15 M(+1.5%) |
June 2022 | $170.53 M(+1.8%) | $46.59 M(+11.8%) | $170.53 M(+0.5%) |
Mar 2022 | - | $41.68 M(+3.2%) | $169.65 M(+0.1%) |
Dec 2021 | - | $40.40 M(-3.5%) | $169.41 M(+0.2%) |
Sept 2021 | - | $41.85 M(-8.4%) | $169.07 M(+0.9%) |
June 2021 | $167.50 M(-1.5%) | $45.71 M(+10.3%) | $167.50 M(+6.9%) |
Mar 2021 | - | $41.44 M(+3.4%) | $156.75 M(+0.0%) |
Dec 2020 | - | $40.06 M(-0.5%) | $156.69 M(-4.2%) |
Sept 2020 | - | $40.28 M(+15.2%) | $163.50 M(-3.8%) |
June 2020 | $169.97 M(+1.4%) | $34.97 M(-15.5%) | $169.97 M(-5.0%) |
Mar 2020 | - | $41.38 M(-11.7%) | $179.00 M(+0.0%) |
Dec 2019 | - | $46.87 M(+0.2%) | $178.97 M(+3.3%) |
Sept 2019 | - | $46.75 M(+6.3%) | $173.21 M(+3.3%) |
June 2019 | $167.70 M(+12.9%) | $43.99 M(+6.4%) | $167.70 M(+3.8%) |
Mar 2019 | - | $41.36 M(+0.6%) | $161.55 M(+2.3%) |
Dec 2018 | - | $41.11 M(-0.3%) | $157.99 M(+2.7%) |
Sept 2018 | - | $41.24 M(+9.0%) | $153.89 M(+3.6%) |
June 2018 | $148.57 M(+3.1%) | $37.85 M(+0.1%) | $148.57 M(+1.3%) |
Mar 2018 | - | $37.80 M(+2.1%) | $146.63 M(+0.3%) |
Dec 2017 | - | $37.01 M(+3.0%) | $146.16 M(+2.1%) |
Sept 2017 | - | $35.92 M(+0.0%) | $143.15 M(-0.7%) |
June 2017 | $144.10 M(-11.3%) | $35.91 M(-3.8%) | $144.10 M(-1.1%) |
Mar 2017 | - | $37.33 M(+9.8%) | $145.74 M(-3.3%) |
Dec 2016 | - | $33.99 M(-7.8%) | $150.75 M(-4.6%) |
Sept 2016 | - | $36.87 M(-1.8%) | $158.01 M(-2.8%) |
June 2016 | $162.54 M(+13.1%) | $37.55 M(-11.3%) | $162.54 M(-0.4%) |
Mar 2016 | - | $42.34 M(+2.6%) | $163.16 M(+1.8%) |
Dec 2015 | - | $41.26 M(-0.3%) | $160.28 M(+5.7%) |
Sept 2015 | - | $41.40 M(+8.4%) | $151.57 M(+5.5%) |
June 2015 | $143.68 M(+21.8%) | $38.17 M(-3.2%) | $143.68 M(+3.2%) |
Mar 2015 | - | $39.45 M(+21.2%) | $139.24 M(+6.1%) |
Dec 2014 | - | $32.55 M(-2.8%) | $131.22 M(+4.0%) |
Sept 2014 | - | $33.51 M(-0.7%) | $126.13 M(+6.9%) |
June 2014 | $117.99 M | $33.73 M(+7.3%) | $117.99 M(+8.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2014 | - | $31.43 M(+14.4%) | $108.89 M(+9.9%) |
Dec 2013 | - | $27.47 M(+8.3%) | $99.12 M(+7.7%) |
Sept 2013 | - | $25.37 M(+3.0%) | $92.07 M(+6.2%) |
June 2013 | $86.72 M(+30.7%) | $24.63 M(+13.8%) | $86.72 M(+7.6%) |
Mar 2013 | - | $21.65 M(+6.0%) | $80.56 M(+6.4%) |
Dec 2012 | - | $20.42 M(+2.0%) | $75.72 M(+6.6%) |
Sept 2012 | - | $20.02 M(+8.4%) | $71.04 M(+7.0%) |
June 2012 | $66.37 M(+6.4%) | $18.47 M(+9.9%) | $66.37 M(+4.2%) |
Mar 2012 | - | $16.81 M(+6.8%) | $63.67 M(+0.6%) |
Dec 2011 | - | $15.73 M(+2.5%) | $63.27 M(+1.7%) |
Sept 2011 | - | $15.35 M(-2.7%) | $62.23 M(-0.2%) |
June 2011 | $62.37 M(-0.1%) | $15.78 M(-3.9%) | $62.37 M(+0.8%) |
Mar 2011 | - | $16.41 M(+11.8%) | $61.90 M(+0.1%) |
Dec 2010 | - | $14.69 M(-5.2%) | $61.86 M(-1.9%) |
Sept 2010 | - | $15.50 M(+1.3%) | $63.09 M(+1.0%) |
June 2010 | $62.45 M(+4.4%) | $15.30 M(-6.6%) | $62.45 M(+1.8%) |
Mar 2010 | - | $16.38 M(+3.0%) | $61.35 M(+3.6%) |
Dec 2009 | - | $15.91 M(+7.1%) | $59.22 M(+27.3%) |
Sept 2009 | - | $14.86 M(+4.6%) | $46.52 M(+24.6%) |
June 2009 | $59.82 M(+285.7%) | $14.20 M(-0.4%) | $37.34 M(+34.3%) |
Mar 2009 | - | $14.25 M(+342.8%) | $27.81 M(+79.3%) |
Dec 2008 | $15.51 M(+19.1%) | $3.22 M(-43.2%) | $15.51 M(+0.0%) |
Sept 2008 | - | $5.67 M(+21.5%) | $15.51 M(+20.9%) |
June 2008 | - | $4.67 M(+139.0%) | $12.82 M(+12.1%) |
Mar 2008 | - | $1.95 M(-39.3%) | $11.44 M(-12.2%) |
Dec 2007 | $13.02 M(+6.8%) | $3.22 M(+7.7%) | $13.02 M(-2.2%) |
Sept 2007 | - | $2.99 M(-8.9%) | $13.31 M(-6.2%) |
June 2007 | - | $3.28 M(-7.2%) | $14.19 M(+3.1%) |
Mar 2007 | - | $3.54 M(+0.7%) | $13.77 M(+13.0%) |
Dec 2006 | $12.19 M(+128.7%) | $3.51 M(-9.1%) | $12.19 M(+40.5%) |
Sept 2006 | - | $3.86 M(+35.2%) | $8.68 M(+80.3%) |
June 2006 | - | $2.86 M(+46.4%) | $4.81 M(+146.4%) |
Mar 2006 | - | $1.95 M | $1.95 M |
Dec 2005 | $5.33 M(+78.0%) | - | - |
Dec 2004 | $2.99 M(+134.8%) | - | - |
Dec 2002 | $1.27 M | - | - |
FAQ
- What is Cardiovascular Systems annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Cardiovascular Systems?
- What is Cardiovascular Systems quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Cardiovascular Systems?
- What is Cardiovascular Systems TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Cardiovascular Systems?
What is Cardiovascular Systems annual selling, general & administrative expenses?
The current annual SG&A of CSII is $170.53 M
What is the all time high annual SG&A for Cardiovascular Systems?
Cardiovascular Systems all-time high annual selling, general & administrative expenses is $170.53 M
What is Cardiovascular Systems quarterly selling, general & administrative expenses?
The current quarterly SG&A of CSII is $41.64 M
What is the all time high quarterly SG&A for Cardiovascular Systems?
Cardiovascular Systems all-time high quarterly selling, general & administrative expenses is $46.87 M
What is Cardiovascular Systems TTM selling, general & administrative expenses?
The current TTM SG&A of CSII is -$1.72 B
What is the all time high TTM SG&A for Cardiovascular Systems?
Cardiovascular Systems all-time high TTM selling, general & administrative expenses is $179.00 M